Progyny (PGNY) Common Equity (2018 - 2026)

Progyny (PGNY) has 9 years of Common Equity data on file, last reported at $439.3 million in Q1 2026.

• On a quarterly basis, Common Equity fell 5.95% year-over-year to $439.3 million in Q1 2026; TTM through Mar 2026 was $439.3 million, a 5.95% decrease from a year earlier, with the FY2025 full-year figure at $516.0 million, up 22.27% from the prior year.
• Common Equity for Q1 2026 stood at $439.3 million, down from $516.0 million in the prior quarter.
• Over the last five years, Common Equity for PGNY reached as high as $571.6 million in Q1 2024 and fell as low as $279.6 million in Q1 2022.
• Historically, Common Equity has averaged $450.6 million across 5 years, with a median of $456.2 million in 2024.
• Across the five-year window, Common Equity surged 54.77% in 2022 and retreated 23.74% in 2024, its largest moves.
• Year by year, Common Equity stood at $377.0 million in 2022, then jumped by 46.81% to $553.4 million in 2023, then slipped by 23.74% to $422.1 million in 2024, then rose by 22.27% to $516.0 million in 2025, then declined by 14.86% to $439.3 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $439.3 million in Q1 2026, $516.0 million in Q4 2025, and $560.0 million in Q3 2025.